LYNPARZA is covered by Medicare and 100 percent of Medicare prescription drug plans cover Lynparza.
Most health insurance will also cover Lynparza but you may need to pay a small copay.
LYNPARZA is approved in the US and was approved by the FDA on May 31st 2023.
LYNPARZA is not considered a chemotherapy.
Lynparza is a non chemotherapy cancer medication that is a PARP inhibitor, that inhibits poly ADP ribose polymerase, which is an enzyme that is involved in repair of DNA.
The drug Lynparza is used to treat certain types of advanced cancer that has come back after previous treatment and for women that have been newly diagnosed with advanced cancer.
Lynparza is often used to treat primary peritoneal cancer, fallopian tube cancer, prostate cancer, pancreatic cancer, ovarian cancer and breast cancer.
The drug Lynparza can also be used to treat early breast cancer which has a high risk of coming back.
If your doctor determines that Lynparza is safe and effective for you, you'll likely take the drug Lynparza long term.
Lynparza treatment for ovarian cancer can last for up to 2 years or as long as the drug is safe and effective for you.
The success rate of Lynparza is 61 percent.
Lynparza is worth taking as research has found that the drug Lynparza decreased a persons' risk of recurrence of invasive breast cancer and increased the length of time of no signs or symptoms of cancer.
At three years, 85.9% of people who took Lynparza were alive without invasive breast cancer, compared with 77.1% of people in the placebo group.
When taking Lynparza you should avoid grapefruit, grapefruit juice, Seville oranges, and Seville orange juice during treatment with LYNPARZA since they may increase the level of LYNPARZA in your blood.
The cost for Lynparza 100 mg oral tablet is around $8,883.00 for a supply of 60 tablets, depending on the pharmacy you get it from.
100 percent of Medicare plans will cover the cost of Lynparza and most other health insurance plans will also cover the cost of Lynparza.
The risks and possible side effects of Lynparza are fatigue, asthenia, abdominal pain, vomiting and anemia.